CoChat

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

Open access

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The polycystic ovary syndrome is a common cause of infertility. Clomiphene and insulin sensitizers are used alone and in combination to induce ovulation, but it is unknown whether one approach is superior. METHODS: We randomly assigned 626 infertile women with the polycystic ovary syndrome to receive clomiphene citrate plus placebo, extended-release metformin plus placebo, or a combination of metformin and clomiphene for up to 6 months. Medication was discontinued when pregnancy was confirmed, and subjects were followed until delivery. RESULTS: The live-birth rate was 22.5% (47 of 209 subjects) in the clomiphene group, 7.2% (15 of 208) in the metformin group, and 26.8% (56 of 209) in the combination-therapy group (P<0.001 for metformin vs. both clomiphene and combination therapy; P=0.31 for clomiphene vs. combination therapy). Among pregnancies, the rate of multiple pregnancy was 6.0% in the clomiphene group, 0% in the metformin group, and 3.1% in the combination-therapy group. The rates of first-trimester pregnancy loss did not differ significantly among the groups. However, the conception rate among subjects who ovulated was significantly lower in the metformin group (21.7%) than in either the clomiphene group (39.5%, P=0.002) or the combination-therapy group (46.0%, P<0.001). With the exception of pregnancy complications, adverse-event rates were similar in all groups, though gastrointestinal side effects were more frequent, and vasomotor and ovulatory symptoms less frequent, in the metformin group than in the clomiphene group. CONCLUSIONS: Clomiphene is superior to metformin in achieving live birth in infertile women with the polycystic ovary syndrome, although multiple birth is a complication. (ClinicalTrials.gov number, NCT00068861 [ClinicalTrials.gov].).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa063971

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 38 references

Research works printed but not linked: 4

  1. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992:377-84. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Re- vised 2003 consensus on diagnostic crite- ria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
  2. 2004, Fertil Steril, 81, 19
  3. The New England Journal of Medicine Downloaded from nejm.org on August 29, 2023. For personal use only. No other uses without permission. Copyright © 2007 Massachusetts Medical Society. All rights reserved. n engl j med 356;
  4. www.nejm.org february 8, 2007 566 Clomiphene versus Metformin in the Polycystic Ovary Syndrome ovary syndrome: a prospective parallel randomized double-blind placebo-con- trolled trial. J Clin Endocrinol Metab 2004; 89:4801-9. [Erratum, J Clin Endocrinol Metab 2005;90:3945.]

Cited by

Items 701–800 of 1,000

Metadata

Authors
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., Gosman, G. G., Nestler, J. E., Giudice, L. C., Leppert, P. C., & Myers, E. R.
Affiliations
  • Pennsylvania State University (US)
  • Duke Medical Center (US)
  • University of Colorado Denver (US)
  • The University of Texas Southwestern Medical Center (US)
  • Wayne State University (US)
  • Baylor College of Medicine (US)
  • University of Alabama at Birmingham (US)
  • University of Pennsylvania (US)
  • University of Medicine and Dentistry of New Jersey (US)
  • Stanford University (US)
  • University of Pittsburgh (US)
  • Virginia Commonwealth University (US)
  • University of California, San Francisco (US)
  • National Institutes of Health (US)
Venue
New England Journal of Medicine
Published
2007-02-08
Volume
356
Issue
6
Pages
551-566
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2138595862
Cited by
1,027
References
37
Citations by year
2026: 17 · 2025: 23 · 2024: 32 · 2023: 41 · 2022: 50 · 2021: 43 · 2020: 35 · 2019: 36 · 2018: 39 · 2017: 59 · 2016: 46 · 2015: 64 · 2014: 46 · 2013: 68 · 2012: 63
FWCI
107.19
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • VCU Scholars Compass (Virginia Commonwealth University) (submittedVersion)
Funders
  • National Institutes of Health
  • National Center for Research Resources (M01-RR00056, M01 RR10732, C06RR016499, M01RR000056, M01RR010732)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U10HD033172, U10HD038999, U54-HD29834, U10HD27049, U10HD039005, U10-HD38992, U10 HD27011, U10-HD39005, U10HD027011, U10 HD38999, U10HD038998, U01HD038997, U10-HD38998, U01-HD38997, U10-HD38988, U10HD038988, U10HD027049, U10 HD33172, U10HD038992)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Keywords
polycystic ovary syndrome, infertility, clomiphene citrate, metformin, ovulation induction, live birth rate, multiple pregnancy, conception rate, early pregnancy loss, insulin sensitizers, combination therapy
MeSH terms
Adult, Birth Rate, Clomiphene, Drug Therapy, Combination, Female, Fertility Agents, Female, Humans, Hypoglycemic Agents, Infertility, Female, Metformin, Ovulation Induction, Patient Compliance, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Complications, Pregnancy, Multiple, Live Birth, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.